Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy
JAMA Oncol
.
2018 Dec 1;4(12):1784-1785.
doi: 10.1001/jamaoncol.2018.4625.
Authors
Melanie D Whittington
1
,
Daniel A Ollendorf
2
,
Jonathan D Campbell
1
Affiliations
1
University of Colorado Anschutz Medical Campus, Aurora.
2
Institute for Clinical and Economic Review, Boston, Massachusetts.
PMID:
30325984
DOI:
10.1001/jamaoncol.2018.4625
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunologic Factors
Immunotherapy
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*
T-Lymphocytes*
Substances
Immunologic Factors
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen